A comprehensive review of SARS-CoV-2-associated multisystem inflammatory syndrome in children

Mojtaba Yousefi Zoshk; Melika Zamanian; Melika Farshidianfar; Alireza Masoumi; Mohammad Mobin Mirimoghaddam; Elahe Bakhshi; Anoush Azarfar

Articles in Press, Accepted Manuscript, Available Online from 11 December 2022


  The coronavirus disease 2019 (COVID-19) has afflicted individuals of all ages, which has a high rate of morbidity and fatality. Although most children with COVID-19 infection experience minor symptoms, a growing proportion of COVID-19 infections in children are linked to a novel multisystem inflammatory ...  Read More

The Most Common Treatable Neurometabolic Epilepsies in Children

Parvaneh Karimzadeh; Sasan Saket

Volume 5, Issue 2 , June 2018, , Pages 59-66


  Epilepsy is a common neurological disorder in childhood with prominent neurological manifestations, signs, and symptoms in inherited neurometabolic disorders. Accurate diagnosis of neurometabolic disorders in epileptic patients increases the possibility of a specific treatment to improve epilepsy. Therefore, ...  Read More

Effect of valproic acid on metabolic status and endocrine system in pediatric patients with epilepsy: systematic literature review

Sona Sepahi; Bamdad Riahi-Zanjani; Adel Ghorani-Azam

Volume 4, Issue 1 , January 2017, , Pages 7-13


  Introduction: Valproic acid (VPA) is an acidic compound that is commonly used as an anticonvulsant and mood-stabilizing agent in the treatment of epilepsy, mania and bipolar disorders as well as the prevention of migraine headaches. But, it can affect metabolic and endocrine system resulting in hormonal ...  Read More